We are live on ! Find out more
MIM

Monashee Investment Management Portfolio holdings

AUM $184M
1-Year Est. Return 197.43%
This Fund
S&P 500
This Quarter Est. Return
+24.75%
1 Year Est. Return
+197.43%
3 Year Est. Return
+447.04%
5 Year Est. Return
+479.31%
10 Year Est. Return
+5,610.42%
AUM
$757M
AUM Growth
+$293M
Cap. Flow
+$210M
Cap. Flow %
27.7%
Top 10 Hldgs %
37.11%
Holding
384
New
211
Increased
9
Reduced
13
Closed
104

Top Buys

Rank Stock Value
1
SGTX
Sigilon Therapeutics, Inc. Common Stock
SGTX
+$19.6M
2
SPRU icon
Spruce Power Holding Corp
SPRU
+$16.2M
3
SHC icon
Sotera Health
SHC
+$10.7M
4
FHTX icon
Foghorn Therapeutics
FHTX
+$10.7M
5
SNRHU
Senior Connect Acquisition Corp. I Unit
SNRHU
+$10.3M

Top Sells

Rank Stock Value
1
VTI icon
Vanguard Morningstar Total Stock Market ETF
VTI
+$38.1M
2
CZR icon
Caesars Entertainment
CZR
+$18.8M
3
GDRX icon
GoodRx Holdings
GDRX
+$8.9M
4
SNOW icon
Snowflake
SNOW
+$6.28M
5
STEP icon
StepStone Group
STEP
+$5.99M

Sector Composition

Rank Sector Weight
1 Healthcare 30.35%
2 Financials 10.57%
3 Consumer Discretionary 9%
4 Technology 5.91%
5 Industrials 4.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
FLACU
126
DELISTED
Frazier Lifesciences Acquisition Corporation Unit
FLACU
$1.56M 0.21%
+150,000
New +$1.57M
PACB icon
127
Pacific Biosciences
PACB
$357M
$1.56M 0.21%
60,000
+20,000
+50% +$340K
AVAN
128
DELISTED
Avanti Acquisition Corp.
AVAN
$1.54M 0.2%
+149,996
New +$1.5M
LGVW.WS
129
DELISTED
Longview Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one share of Clas
LGVW.WS
$1.54M 0.2%
233,332
– –
SEAH
130
DELISTED
Sports Entertainment Acquisition Corp.
SEAH
$1.52M 0.2%
+149,998
New +$1.5M
YSAC
131
DELISTED
Yellowstone Acquisition Company
YSAC
$1.52M 0.2%
+149,998
New +$1.54M
PIAI
132
DELISTED
Prime Impact Acquisition I
PIAI
$1.51M 0.2%
+149,997
New +$1.49M
IACA
133
DELISTED
ION Acquisition Corp 1 Ltd.
IACA
$1.47M 0.19%
+124,990
New +$1.35M
PTGX icon
134
Protagonist Therapeutics
PTGX
$9.71B
$1.41M 0.19%
+70,000
New +$1.51M
STEM icon
135
Stem
STEM
$50.9M
$1.41M 0.19%
+3,440
New +$867K
NTLA icon
136
Intellia Therapeutics
NTLA
$1.68B
$1.36M 0.18%
+25,000
New +$908K
ETWO
137
DELISTED
E2open Parent Holdings
ETWO
$1.35M 0.18%
124,997
-50,000
-29% -$517K
OBIO icon
138
Orchestra BioMed
OBIO
$267M
$1.28M 0.17%
100,000
– –
BLSA
139
DELISTED
BCLS Acquisition Corp. Class A Ordinary Shares
BLSA
$1.28M 0.17%
+115,000
New +$1.23M
EQD
140
DELISTED
Equity Distribution Acquisition Corp.
EQD
$1.28M 0.17%
+124,998
New +$1.26M
KPLT icon
141
Katapult Holdings
KPLT
$31.6M
$1.25M 0.17%
+4,000
New +$1.05M
OCUL icon
142
Ocular Therapeutix
OCUL
$2.03B
$1.24M 0.16%
+60,000
New +$891K
STOK icon
143
Stoke Therapeutics
STOK
$2.08B
$1.24M 0.16%
+20,000
New +$917K
MRNS
144
DELISTED
Marinus Pharmaceuticals, Inc
MRNS
$1.22M 0.16%
+100,000
New +$1.39M
ICHR icon
145
Ichor Holdings
ICHR
$2.43B
$1.21M 0.16%
+40,000
New +$1.13M
SKIN icon
146
SkinHealth Systems
SKIN
$82.9M
$1.13M 0.15%
+99,993
New +$1.08M
HMCOU
147
DELISTED
HumanCo Acquisition Corp. Unit
HMCOU
$1.1M 0.15%
+100,000
New +$1.11M
OPAD icon
148
Offerpad Solutions
OPAD
$22.9M
$1.1M 0.15%
+667
New +$1.08M
MKFG
149
DELISTED
Markforged Holding Corporation
MKFG
$1.08M 0.14%
+10,000
New +$1.03M
VLTA
150
DELISTED
Volta Inc.
VLTA
$1.06M 0.14%
+100,000
New +$1.05M
4 5
6
7 8

Similar funds

SWMG
Sard Wealth Management Group Atlanta, Georgia $184M AUM 11.26% 1-Year Est. Return
IFPL
Investments & Financial Planning LLC Lexington, Kentucky $184M AUM 17.7% 1-Year Est. Return
RFG
RFP Financial Group Atlanta, Georgia $184M AUM 16.06% 1-Year Est. Return
NAM
Nutshell Asset Management Sevenoaks, United Kingdom $184M AUM 2.02% 1-Year Est. Return
GCGM
General Catalyst Group Management Cambridge, Massachusetts $184M AUM 50.45% 1-Year Est. Return
PSAMP
P. Schoenfeld Asset Management (PSAM) New York $184M AUM 97.09% 1-Year Est. Return
GCA
GSI Capital Advisors Newport Beach, California $184M AUM 5.17% 1-Year Est. Return
IVGAV
Index Venture Growth Associates V St. Helier, Jersey $184M AUM

Monashee Investment Management's Q4 2020 Portfolio in Review

As of Q4 2020, Monashee Investment Management held 384 positions worth $757M, up 63% from $464M the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Monashee Investment Management deployed $210M of net new capital in Q4 2020, opening 211 new positions and adding to 9 existing holdings. Its largest new stake was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, up from 19% a quarter earlier, followed by Financials and Consumer Discretionary.

On the sell side, the largest reduction was Vanguard Morningstar Total Stock Market ETF, an estimated $38.1M trimmed.

  • Monashee Investment Management's largest Q4 2020 buy was Sigilon Therapeutics, Inc. Common Stock: 43,202 shares worth $27M.
  • Monashee Investment Management added most to Quanterix in Q4 2020, an estimated $8.95M increase.
  • Monashee Investment Management's biggest Q4 2020 reduction was Vanguard Morningstar Total Stock Market ETF, cutting an estimated $38.1M.
  • Monashee Investment Management fully exited Caesars Entertainment in Q4 2020, selling an estimated $18.8M.
  • Monashee Investment Management's ten largest holdings make up 37% of its $757M portfolio in Q4 2020.
  • Monashee Investment Management opened 211 new positions and closed 104 in Q4 2020.
  • Monashee Investment Management's portfolio value rose 63% quarter-over-quarter to $757M.

Based on Monashee Investment Management's 13F filing for Q4 2020, filed 11 Feb 2021.